Telratolimod
- Generic Name
- Telratolimod
A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 53
- Registration Number
- NCT02556463
- Locations
- 🇫🇷
Research Site, Villejuif, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath